HCPLive Network

Sleep Restriction Affects Respiratory, Vascular Control

FRIDAY, April 26 (HealthDay News) -- Partial sleep deprivation leads to less healthy vascular function and impaired breathing control, according to a study presented at Experimental Biology 2013, held from April 20 to 24 in Boston.

Keith Pugh, from the University of Birmingham, in the United Kingdom, and colleagues assessed chemosensitivity and endothelial function (measured by flow-mediated dilation) in eight participants assigned to either a sleep restriction protocol consisting of a baseline night of eight hours sleep, followed by three nights of four hours sleep, or a control protocol consisting of the same initial night followed by three nights of 10 hours of sleep opportunity.

The researchers found that, in the sleep restriction group, central chemosensitivity increased by 51.6 ± 9.4 percent after the second night of sleep restriction but returned to baseline after the third night. Central chemosensitivity remained unchanged in the control group. There was no difference in peripheral chemosensitivity between the two protocols. After the second night of sleep restriction, endothelial function decreased by 46.7 ± 1.6 percent but recovered after the third night. The control group did not experience changes in endothelial function.

"If acute sleep loss occurs repetitively over a long period of time, then vascular health could be compromised further and eventually mediate the development of cardiovascular disease," Pugh said in a statement.

Press Release
More Information

Copyright © 2013 HealthDay. All rights reserved.
Further Reading
Although patients are expressing more of an interest in accessing their health information online, just a third of patients have access to patient portals, and the rest either don't have access or are not sure if they do.
As more pediatric surgical procedures being conducted as same-day procedures, parents are assuming responsibility for their children’s immediate post-operative pain management.
Between developing its own pipeline of therapies for patients with hepatitis C and acquiring another company known for its work in this field, it looks like Merck is taking steps to be a larger player in HCV market.
There is a significantly increased risk of cardiac death associated with clarithromycin use, according to a study published online Aug. 19 in BMJ.
As the 2 Americans stricken with Ebola continue to receive treatment in Atlanta, a new potential case of the deadly virus has been reported in California.
Active surveillance for clinical stage I testis cancer leads to excellent outcomes, according to a study published online Aug. 18 in the Journal of Clinical Oncology.
Pistachio consumption is associated with improvements in glucose and cardiometabolic parameters, according to a study published online Aug. 14 in Diabetes Care.
More Reading